Cardiovascular complications in COVID-19

By B. Long, W. Brady, A. Koyfman, M. Gottlieb. American Journal of Emergency Medicine, 2020

965 citations recorded by the source corpus.

Background The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and pulmonary complications can result in significant morbidity and mortality, cardiovascular complications may also occur. Objective This brief report evaluates cardiovascular complications in the setting of COVID-19 infection. Discussion The current COVID-19 pandemic has resulted in over one million infected worldwide and thousands of death. The virus binds and enters through angiotensin-converting enzyme 2 (ACE2). COVID-19 can result in systemic inflammation, multiorgan dysfunction, and critical illness. The cardiovascular system is also affected, with complications including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events. Current therapies for COVID-19 may interact with cardiovascular medications. Conclusions Emergency clinicians should be aware of these cardiovascular complications when evaluating and managing the patient with COVID-19.

Subfields: Infectious Diseases, Molecular Biology, Neurology

View Paper: https://www.semanticscholar.org/paper/67e5a2d36f73f1f84a1f5971f97c2c371381e584

Citations in the corpus